PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 217 filers reported holding PORTOLA PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 2.74 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $2,751,000 | -35.7% | 115,194 | -27.8% | 0.16% | -22.2% |
Q3 2019 | $4,278,000 | +304.3% | 159,504 | +634.1% | 0.20% | +534.4% |
Q4 2017 | $1,058,000 | -50.9% | 21,729 | -45.5% | 0.03% | -52.9% |
Q3 2017 | $2,153,000 | +579.2% | 39,839 | +605.7% | 0.07% | +655.6% |
Q2 2017 | $317,000 | – | 5,645 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fernwood Investment Management, LLC | 232,952 | $5,498,000 | 5.39% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,673,727 | $86,700,000 | 3.41% |
Redmile Group, LLC | 1,466,537 | $34,610,000 | 3.31% |
SECTORAL ASSET MANAGEMENT INC | 1,229,382 | $29,013,000 | 3.00% |
HARVEY CAPITAL MANAGEMENT INC | 206,530 | $4,874,000 | 2.44% |
Marcus Capital, LLC | 75,150 | $1,774,000 | 1.87% |
Cormorant Asset Management, LP | 396,000 | $9,346,000 | 1.32% |
Rail-Splitter Capital Management, LLC | 221,414 | $5,225,000 | 1.25% |
Temasek Holdings (Private) Ltd | 6,583,568 | $155,372,000 | 1.21% |
EMERALD MUTUAL FUND ADVISERS TRUST | 636,526 | $15,022,000 | 0.84% |